182 related articles for article (PubMed ID: 10397273)
1. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.
Silva JM; Dominguez G; Garcia JM; Gonzalez R; Villanueva MJ; Navarro F; Provencio M; San Martin S; España P; Bonilla F
Cancer Res; 1999 Jul; 59(13):3251-6. PubMed ID: 10397273
[TBL] [Abstract][Full Text] [Related]
2. Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
Silva JM; Silva J; Sanchez A; Garcia JM; Dominguez G; Provencio M; Sanfrutos L; Jareño E; Colas A; España P; Bonilla F
Clin Cancer Res; 2002 Dec; 8(12):3761-6. PubMed ID: 12473587
[TBL] [Abstract][Full Text] [Related]
3. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.
Domínguez G; Carballido J; Silva J; Silva JM; García JM; Menéndez J; Provencio M; España P; Bonilla F
Clin Cancer Res; 2002 Apr; 8(4):980-5. PubMed ID: 11948103
[TBL] [Abstract][Full Text] [Related]
4. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy.
Silva JM; Garcia JM; Dominguez G; Silva J; Miralles C; Cantos B; Coca S; Provencio M; España P; Bonilla F
Ann Surg Oncol; 2002; 9(1):71-6. PubMed ID: 11829433
[TBL] [Abstract][Full Text] [Related]
5. p53 mutation in plasma DNA and its prognostic value in breast cancer patients.
Shao ZM; Wu J; Shen ZZ; Nguyen M
Clin Cancer Res; 2001 Aug; 7(8):2222-7. PubMed ID: 11489795
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications.
Hu XC; Wong IH; Chow LW
Oncol Rep; 2003; 10(6):1811-5. PubMed ID: 14534701
[TBL] [Abstract][Full Text] [Related]
7. Extracellular tumor DNA in plasma and overall survival in breast cancer patients.
Garcia JM; Garcia V; Silva J; Peña C; Dominguez G; Sanchez A; Sanfrutos L; Provencio M; Millan I; Chaparro D; España P; Bonilla F
Genes Chromosomes Cancer; 2006 Jul; 45(7):692-701. PubMed ID: 16607614
[TBL] [Abstract][Full Text] [Related]
8. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.
Hui R; Macmillan RD; Kenny FS; Musgrove EA; Blamey RW; Nicholson RI; Robertson JF; Sutherland RL
Clin Cancer Res; 2000 Jul; 6(7):2777-87. PubMed ID: 10914724
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite alterations plasma DNA of primary breast cancer patients.
Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
[TBL] [Abstract][Full Text] [Related]
11. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
Chen X; Bonnefoi H; Diebold-Berger S; Lyautey J; Lederrey C; Faltin-Traub E; Stroun M; Anker P
Clin Cancer Res; 1999 Sep; 5(9):2297-303. PubMed ID: 10499596
[TBL] [Abstract][Full Text] [Related]
12. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
13. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
Coulet F; Blons H; Cabelguenne A; Lecomte T; Lacourreye O; Brasnu D; Beaune P; Zucman J; Laurent-Puig P
Cancer Res; 2000 Feb; 60(3):707-11. PubMed ID: 10676657
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
[TBL] [Abstract][Full Text] [Related]
15. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
17. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
18. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and microsatellite instability at RAD52 and RAD54 loci in breast cancer.
Nowacka-Zawisza M; Bryś M; Hanna RM; Zadrozny M; Kulig A; Krajewska WM
Pol J Pathol; 2006; 57(2):83-9. PubMed ID: 17019970
[TBL] [Abstract][Full Text] [Related]
20. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
